Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPP-HPV Program
NCT02994290Completed
- Sponsor
- Yale University
- Start
- Jan 2017
- Primary completion
- Oct 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of human papillomavirus vaccine in human papillomavirus infection (2 arms), sponsored by Yale University. Primary endpoints: Count of Eligible Patients Agreeing to Receive a Dose of Vaccine at 12 months, HPV Vaccine Receptivity Thematic Interview at 6 weeks and 1 more. Started Jan 2017; status: completed.
02
Drugs
human papillomavirus vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT02994290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02994290.